These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 15123278

  • 1. Toxicogenomics in predictive toxicology in drug development.
    Suter L, Babiss LE, Wheeldon EB.
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [Abstract] [Full Text] [Related]

  • 2. The state-of-the-art in predictive toxicogenomics.
    Fielden MR, Kolaja KL.
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
    [Abstract] [Full Text] [Related]

  • 3. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S.
    Mutat Res; 2005 Aug 04; 575(1-2):102-15. PubMed ID: 15924886
    [Abstract] [Full Text] [Related]

  • 4. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA, Vandebriel RJ, Pennings JL, Kleinjans JC, van Loveren H.
    Methods; 2007 Jan 04; 41(1):132-41. PubMed ID: 17161310
    [Abstract] [Full Text] [Related]

  • 5. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET, Zira AN, Theocharis SE.
    J Appl Toxicol; 2007 Jan 04; 27(4):302-9. PubMed ID: 17429800
    [Abstract] [Full Text] [Related]

  • 6. The Japanese toxicogenomics project: application of toxicogenomics.
    Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T.
    Mol Nutr Food Res; 2010 Feb 04; 54(2):218-27. PubMed ID: 20041446
    [Abstract] [Full Text] [Related]

  • 7. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
    Yang Y, Blomme EA, Waring JF.
    Chem Biol Interact; 2004 Nov 01; 150(1):71-85. PubMed ID: 15522262
    [Abstract] [Full Text] [Related]

  • 8. A retrospective analysis of toxicogenomics in the safety assessment of drug candidates.
    Foster WR, Chen SJ, He A, Truong A, Bhaskaran V, Nelson DM, Dambach DM, Lehman-McKeeman LD, Car BD.
    Toxicol Pathol; 2007 Aug 01; 35(5):621-35. PubMed ID: 17654404
    [Abstract] [Full Text] [Related]

  • 9. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P, Sasaki J.
    Mutat Res; 2010 Dec 01; 705(3):165-71. PubMed ID: 20466069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Applications of toxicogenomics to nonclinical drug development: regulatory science considerations.
    Sistare FD, Degeorge JJ.
    Methods Mol Biol; 2008 Dec 01; 460():239-61. PubMed ID: 18449491
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database.
    Kondo C, Minowa Y, Uehara T, Okuno Y, Nakatsu N, Ono A, Maruyama T, Kato I, Yamate J, Yamada H, Ohno Y, Urushidani T.
    Toxicology; 2009 Nov 09; 265(1-2):15-26. PubMed ID: 19761811
    [Abstract] [Full Text] [Related]

  • 17. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):179-88. PubMed ID: 16139318
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA, Bruno ME.
    Curr Opin Mol Ther; 2004 Dec 01; 6(6):600-7. PubMed ID: 15663324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.